« Previous
Next »
American Journal of Cardiology
Volume 97, Issue 8
, Pages 1182-1187
, 15 April 2006
Comparison of Sirolimus Versus Paclitaxel Eluting Stents for Treatment of Coronary In-Stent Restenosis
References
- . Coronary artery stents . JAMA . 2000;284:1828–1836
- . Predictors of diffuse and aggressive intra-stent restenosis . J Am Coll Cardiol . 2001;37:1019–1025
- . Balloon angioplasty for the treatment of coronary in-stent restenosis (immediate results and 6-month angiographic recurrent restenosis rate) . J Am Coll Cardiol . 1998;32:980–984
-
.
Angiographic patterns of in-stent restenosis
(classification and implications for long-term outcome)
.
Circulation
. 1999;100:1872–1878
- . Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis . Am J Cardiol . 1996;78:618–622
- . Stenting the stent (initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis) . Am J Cardiol . 2000;85:327–332
- . Cutting balloon angioplasty for the treatment of in-stent restenosis (a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty) . J Am Coll Cardiol . 2001;38:672–679
- Rotational atherectomy does not reduce recurrent in-stent restenosis (results of the Angioplasty versus Rotational atherectomy for Treatment of diffuse In-Stent restenosis Trial (ARTIST)) . Circulation . 2002;105:583–588
- . Use of localised intracoronary beta radiation in treatment of in-stent restenosis (the INHIBIT randomised controlled trial) . Lancet . 2002;359:551–557
- . Outcome after treatment of coronary in-stent restenosis (results from a systematic review using meta-analysis techniques) . Eur Heart J . 2003;24:266–273
- . Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis . Circulation . 2004;109:340–344
- . Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis (a randomized controlled trial) . JAMA . 2005;293:165–171
- . Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis . Am J Cardiol . 2004;94:1297–1300
- Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents . JAMA . 2005;293:2126–2130
- . Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement . Circulation . 2005;111:2107–2111
- . Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions . Eur Heart J . 2004;25:32–38
- TAXUS III trial (in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation) . Circulation . 2003;107:559–564
- Sirolimus-eluting stent for the treatment of in-stent restenosis (a quantitative coronary angiography and three-dimensional intravascular ultrasound study) . Circulation . 2003;107:24–27
- . Sirolimus-eluting stent for treatment of complex in-stent restenosis (the first clinical experience) . J Am Coll Cardiol . 2003;41:184–189
- . Effectiveness of treatment of in-stent restenosis with an 8-French compatible atherectomy catheter . Am J Cardiol . 2003;92:725–728
- Directional atherectomy for treatment of restenosis within coronary stents (clinical, angiographic and histologic results) . J Am Coll Cardiol . 1992;20:1465–1473
- . Impact of microvascular complications on outcome after coronary stent implantations in patients with diabetes . J Am Coll Cardiol . 2005;45:464–466
- . The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation . J Am Coll Cardiol . 1998;32:584–589
- Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients (insights from the Arterial Revascularization Therapy Study (ARTS) trial) . Circulation . 2001;104:533–538
- . Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery . N Engl J Med . 2003;349:1315–1323
- . Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions . Circulation . 2003;108:788–794
- . A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease . N Engl J Med . 2004;350:221–231
- . Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation (immediate and mid-term results) . J Am Coll Cardiol . 2004;43:1154–1160
- . Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients (an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study) . Circulation . 2004;109:1366–1370
- . Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis (the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial) . Circulation . 2004;110:790–795
PII: S0002-9149(06)00038-5
doi: 10.1016/j.amjcard.2005.11.034
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 97, Issue 8
, Pages 1182-1187
, 15 April 2006
